Skip to main content
PTHS
NASDAQ Life Sciences

Ligand Commits $33.75M to Pelthos PIPE, Holds 49.9% Voting Blocker Ahead of Castle Creek Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$10.78
Mkt Cap
$41.271M
52W Low
$9.02
52W High
$37.5
52W Position info
20% above low
Off High info
71% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PTHS sits 20% above its 52-week low of $9.02.

Summary

Ligand disclosed a binding $33.75 million commitment to Pelthos's pre-merger PIPE — $3.675 million in Castle Creek bridge note plus $30.075 million cash — for Series B preferred converting at $19.67 and warrants struck at $0.0001, alongside a 49.9% voting cap.


Key Events · Ownership and Investor Activity · PTHS

  • Ligand Anchors $33.75M PIPE

    Ligand agreed to buy 33,750 Series B preferred shares (stated value $1,000) plus warrants on 291,688 common shares for $33,750,000, with $3,675,000 paid via transfer of the Castle Creek bridge note and $30,075,000 expected in cash.

  • Conversion and Warrant Terms

    Series B converts at $19.67 per share (voting conversion price $16.54); warrants carry a $0.0001 strike, become exercisable 180 days after closing and run 10 years, with a 49.99% ownership blocker.

  • Ligand Already Holds 38.2%

    Ligand beneficially owns 1,500,000 common shares (~38.2%), 34,278.681 Series A preferred convertible into 3,427,868.1 shares (~66.6% of Series A), and a $9.0M convertible note for 261,309 shares, capped at 49.9% of voting power.

  • PIPE Needs $57.5M to Close

    The Concurrent Financing requires at least $57.5 million from investors and closes immediately before the merger; the merger has a February 1, 2027 outside date, extendable to March 31, 2027.


Analysis · PTHS · Life Sciences

Ligand, already Pelthos's largest holder at roughly 38.2% of the common stock, is anchoring the PIPE that must close before the Castle Creek merger can complete. It is buying 33,750 Series B preferred shares at $1,000 stated value plus warrants on 291,688 common shares for $33.75 million, of which $3.675 million is paid by handing Pelthos a Castle Creek bridge note it already owns and $30.075 million in cash. The Series B converts at $19.67 — well above today's $10.78 — so the effective share count from this tranche is smaller than the headline dollars suggest, but the 49.99% ownership cap and the $0.0001 warrant strike leave Ligand with a dominant, cheaply expandable stake. The deal still needs at least $57.5 million in total PIPE commitments, an effective S-4, HSR clearance and NYSE American listing approval, with a February 1, 2027 outside date (extendable to March 31, 2027).

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PTHS was trading at $10.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.3M. The 52-week trading range was $9.02 to $37.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PTHS - Latest Insights

PTHS
Nov 12, 2026, 4:54 PM EST
Filing Type: 425
Importance Score:
7
Price at Filing: $8.03
Real-time Price: $6.38 info
Change: -$1.65 (-21%) info
Market Cap: $25.078M info
PTHS
Nov 12, 2026, 7:16 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.39
Real-time Price: $6.38 info
Change: -$3.01 (-32%) info
Market Cap: $25.078M info
PTHS
Nov 12, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.39
Real-time Price: $6.38 info
Change: -$3.01 (-32%) info
Market Cap: $25.078M info
PTHS
Oct 30, 2026, 9:20 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $19.86
Real-time Price: $6.38 info
Change: -$13.48 (-68%) info
Market Cap: $25.078M info
PTHS
Oct 30, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $20.00
Real-time Price: $6.38 info
Change: -$13.62 (-68%) info
Market Cap: $25.078M info